Thursday, July 30, 2015 11:35:06 AM
Training will be paramount on new RASDs that are released to the market. IMO, the entire industry needs a reformat to introduce centers of excellence to maximize technique and patient outcomes using these devices.
I know of surgeons and surgical centers that are "world-renowned" and do some of the highest volume of procedures in the world and their outcomes are inferior to other surgeons and centers that do much lower volumes. You wouldn't know this unless you have seen the data behind the surgeries (which is not published). They are using the same Da Vinci robot as other physicians, so one can only assume that their training or technique is producing poor results in comparison to the rest of the industry. Scary.
Titan will need to take a very calculated approach to selecting doctors for their trials, initial roll out and proctorship/training programs. Not only is the industry not controlled properly IMO, but it will be an entirely new device. I think Titan knows this and is acting accordingly based off previous new of training partnerships and what not.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM